Dr. Karan: Hormone Therapy = Massive Health Benefits
Peer-Reviewed Research
Key Takeaways
- Consider hormone therapy (HRT) during menopause/perimenopause – it provides better cardiovascular disease prevention than statins or blood pressure meds.
- Prioritize bone health – 50% of untreated menopausal women develop osteoporosis, with 1 in 3 suffering hip fractures.
- HRT strengthens bones and significantly reduces osteoporosis risk compared to no treatment.
Notable Quotes
“I’m actually really scared of osteoporosis of my spine… women with osteoporosis of their spine. They cough, they have a small fracture, they’re in pain, they can’t digest very well, they’re on opioids, they’re on laxatives, they’re not very mobile.”
Bottom Line
Menopausal women should seriously consider HRT for both cardiovascular protection and osteoporosis prevention – it’s more effective than standard medications for these conditions.
Explore More
- Dr. Karan’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
- Bryan Johnson: Your day doesn’t begin when you wake up, it begins the night before.
- Siim Land: Is Your Sleep Schedule Causing Arterial Plaque?
- Ben Greenfield: How To Get Six-Pack Abs (RESULTS GUARANTEED)
- Ben Greenfield: Peptides, Muse Cells, & Regenerative Medicine: How to Upgrade Recovery, Joints, & Longevity
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network